Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Sociodemographic characteristics are associated with participating in cancer screening and trials. We compared the characteristics of those responding with those not responding to a single invitation for prostate-specific antigen (PSA) testing for prostate cancer as part of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP). METHODS: Age, rurality and deprivation among 197,763 men from 271 cluster-randomised primary care centres in the UK were compared between those responding (n = 90,300) and those not responding (n = 100,953) to a prostate cancer testing invitation. RESULTS: There was little difference in age between responders and nonresponders. Responders were slightly more likely to come from urban rather than rural areas and were slightly less deprived than those who did not respond. CONCLUSION: These data indicate similarities in age and only minor differences in deprivation and urban location between responders and nonresponders. These differences were smaller, but in the same direction as those observed in other screening trials. TRIAL REGISTRATION: ISRCTN92187251 . Registered on 29 November 2004.

Original publication




Journal article



Publication Date





PSA testing, Prostate cancer, Prostate specific antigen testing, Randomised controlled trial, Screening, Age Factors, Aged, Early Detection of Cancer, Health Behavior, Health Knowledge, Attitudes, Practice, Humans, Kallikreins, Male, Middle Aged, Patient Acceptance of Health Care, Patient Selection, Predictive Value of Tests, Prostate-Specific Antigen, Prostatic Neoplasms, Research Subjects, Socioeconomic Factors, United Kingdom